0DRV.L
BIOTEC PHARMACON ASA BIOTEC PHA
£20.70
+3.50%
2026-05-28
About BIOTEC PHARMACON ASA BIOTEC PHA
ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; and double-strand specific DNases and derived kits for the removal of double stranded DNA. It also provides DNA/RNA polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. The company serves the molecular tools market, and biomanufacturing markets. It operates in Norway, Germany, Lithuania, France, Italy, the United Kingdom, rest of Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway.
Key Fundamentals
P/E Ratio
0.22
EPS (TTM)
£0.94
ROE
4.1%
Revenue Growth (YoY)
40.9%
Profit Margin
10.5%
Debt/Equity
5.63
Price/Book
3.11
Beta
0.51
Avg Volume (10D)
1K
Recent Breakout Signals
No recent breakout signals detected for 0DRV.L.
Recent Price Range (60 Days)
60D High
£28.40
60D Low
£18.85
Avg Volume
2K
Latest Close
£20.70
Get breakout alerts for 0DRV.L
Sign up for Breakout Scanner to receive daily notifications when 0DRV.L triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
BIOTEC PHARMACON ASA BIOTEC PHA (0DRV.L) is listed on the London Stock Exchange (LSE). Breakout Scanner monitors 0DRV.L daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups.. Data is provided for informational purposes only and does not constitute financial advice.